Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
2.740
-0.020 (-0.72%)
At close: Mar 9, 2026, 4:00 PM EDT
2.750
+0.010 (0.36%)
After-hours: Mar 9, 2026, 4:04 PM EDT
Cellectar Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -21.79 | -44.58 | -42.77 | -31.79 | -24.12 | |
| Depreciation & Amortization | 0.21 | 0.29 | 0.19 | 0.15 | 0.15 | |
| Loss (Gain) From Sale of Assets | - | 0.15 | - | 0 | 0 | |
| Stock-Based Compensation | 2.26 | 4.27 | 2.41 | 1.45 | 1.12 | |
| Other Operating Activities | -0.68 | -5.99 | 4.32 | 3.28 | 0.08 | |
| Change in Accounts Payable | -3.16 | -1.59 | 3.7 | 1.62 | 0.41 | |
| Change in Other Net Operating Assets | 0.03 | -0.13 | -0.22 | 0.06 | -0.21 | |
| Operating Cash Flow | -23.12 | -47.58 | -32.38 | -25.22 | -22.57 | |
| Capital Expenditures | -0.01 | -0.1 | -0.86 | -0.23 | -0.14 | |
| Investing Cash Flow | -0.01 | -0.1 | -0.86 | -0.23 | -0.14 | |
| Issuance of Common Stock | 13.03 | 61.41 | 22.94 | 9.61 | 1.25 | |
| Financing Cash Flow | 13.03 | 61.41 | 22.94 | 9.61 | 1.25 | |
| Net Cash Flow | -10.09 | 13.72 | -10.3 | -15.84 | -21.46 | |
| Free Cash Flow | -23.12 | -47.69 | -33.24 | -25.45 | -22.71 | |
| Free Cash Flow Per Share | -8.87 | -38.52 | -81.60 | -108.20 | -122.72 | |
| Levered Free Cash Flow | -16.43 | -43.97 | -8.99 | -8.83 | -13.63 | |
| Unlevered Free Cash Flow | -16.43 | -43.97 | -8.99 | -8.83 | -13.63 | |
| Change in Working Capital | -3.13 | -1.73 | 3.48 | 1.68 | 0.2 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.